Dáil Éireann Debate, Tuesday - 9 April 2019
329. Deputy Louise O'Reilly asked the Minister for Health his plans to conclude the governance review of the drugs approval and procurement process by the end of the second quarter of 2019, as per the Sláintecare action plan (details supplied); and if he will make a statement on the matter. [16122/19]
View answer330. Deputy Louise O'Reilly asked the Minister for Health if the review of the drugs approval and procurement process will include the opportunity for public consultation; and if he will make a statement on the matter. [16123/19]
View answer331. Deputy Louise O'Reilly asked the Minister for Health if a final report will be made publicly available following the completion of the governance review of the drugs approval and procurement process; and if he will make a statement on the matter. [16124/19]
View answerI propose to take Questions Nos. 329 to 331, inclusive, together.
My Department has completed a tender process for a review of the HSE reimbursement and pricing decision-making process and is currently appointing a consultancy firm to complete this review.
The review is expected to be completed within three months of commencement.
Although not included in the terms of reference, consideration will be given to consultation with relevant stakeholders. Consideration will also be given, in due course, to publication of a final report.
